(0.16%) 5 477.90 points
(0.04%) 39 128 points
(0.49%) 17 805 points
(0.06%) $80.88
(-5.04%) $2.62
(-0.90%) $2 309.80
(-0.36%) $28.77
(2.90%) $1 015.00
(0.35%) $0.936
(0.63%) $10.67
(0.51%) $0.792
(0.87%) $88.25
-1.65% $ 0.759
Live Chart Being Loaded With Signals
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases...
Stats | |
---|---|
Volumen de hoy | 276 250 |
Volumen promedio | 391 306 |
Capitalización de mercado | 87.32M |
EPS | $-0.260 ( Q1 | 2024-05-13 ) |
Próxima fecha de ganancias | ( $-0.110 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.460 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00100 (0.13%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-06 | Jovan-embiricos Morana | Buy | 35 000 | Common Stock |
2024-06-06 | Hallal David | Buy | 35 000 | Common Stock |
2024-06-06 | Adams Derek N. | Buy | 35 000 | Common Stock |
2024-06-06 | Bornstein Jeffrey S | Buy | 35 000 | Common Stock |
2024-06-06 | Brenner Malcolm | Buy | 35 000 | Common Stock |
INSIDER POWER |
---|
83.20 |
Last 98 transactions |
Buy: 4 830 870 | Sell: 292 268 |
Volumen Correlación
AlloVir, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
OZEM | 1 |
JVA | 0.865 |
JAN | 0.857 |
MDWD | 0.857 |
SWAV | 0.85 |
FANG | 0.85 |
RZLT | 0.849 |
GBDC | 0.848 |
DXJS | 0.843 |
APXI | 0.84 |
10 Correlaciones Más Negativas | |
---|---|
APTO | -0.895 |
SSTI | -0.891 |
PLRX | -0.887 |
PACB | -0.887 |
VALU | -0.883 |
LAZR | -0.881 |
FOXF | -0.879 |
AUUD | -0.877 |
UONEK | -0.875 |
FLGT | -0.874 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
AlloVir, Inc. Correlación - Moneda/Commodity
AlloVir, Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-398 000 (0.00 %) |
EPS: | $-1.830 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-398 000 (0.00 %) |
EPS: | $-1.830 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.57M (0.00 %) |
EPS: | $-2.20 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-6.39 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
AlloVir, Inc.
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico